Please Wait...

CGA // Chromogranin A

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Chromogranin A (CGA) is a neurosecretory protein initially identified in bovine adrenal medulla and produced simultaneously with catecholamines (Banks and Helle, 1965). CGA is the pro-hormone of at least three biologically active peptides generated by proteolytic cleavages: vasostatin, pancreastatin and parastatin, and also of two other peptides with antimicrobial and antifungal activities (catestatin and chromofungin). CGA circulates at low levels in normal subjects and elevated serum levels have been found in patients with neuroendocrine tumors, renal failure, hypertension, some inflammatory diseases, sepsis and subjects treated with proton pump inhibitors (Angelone et al., 2012; Helle and Corti, 2015).

Bioclinica Lab employs a manual sandwich radioimmunoassay designed for the measurement of whole and fragmented Chromogranin A in serum.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Greetings from @DrugInfoAssn's DIA China from team @bioclinica : Haibing Xie; Shuang Zhou; Pencheng Ha; Angel Y.; M… https://t.co/m7cDDYEl5U
bioclinica (Yesterday)
Greetings from Beijing where David Kiger discussed the value of #AI in medical imaging along w optimization of EDC/… https://t.co/AJWNmaivpm
bioclinica (Yesterday)
We're hiring recent tech grads in #RTP for #pharma sector! Our innov. clinical financial solution gives our client… https://t.co/GHgOfszO0T
bioclinica (2 days ago)
Great to be @DrugInfoAssn DIA China! Ask us @bioclinica how sponsors & CROs can optimize electronic data capture… https://t.co/TtE4AiLnqY
bioclinica (2 days ago)
RT @bioclinica: Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technology for m…
bioclinica (2 days ago)
RT @bioclinica: Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen